Case Name:
Embry v. A. Loacker, USA, Inc.
Court Name:
Alameda County Superior Court
Injunctive Relief:
2.1 Reformulation of the Covered Products
Commencing on the Effective Date, and continuing thereafter, Defendant Releasees shall only manufacture, ship, sell, or offer for sale Covered Products that: (a) contain an average acrylamide concentration by weight (the “Average Level”) of 115 parts per billion or less; or (b) are labeled with a clear and reasonable warning pursuant to Section 2.2. The Average Level shall be determined: (a) by randomly selecting and testing at least one sample each from five different lots of the product (or the maximum number of lots available for testing if less than five) that were produced on dates spread out roughly evenly over a period of at least 60 days; and (b) using tests performed by a laboratory accredited by the State of California, a federal agency, or a nationally recognized accrediting organization, using LC-MS/MS (Liquid Chromatograph-Mass Spectrometry).
2.2 Clear and Reasonable Warnings
Commencing on the Effective Date and continuing thereafter, Defendant Releasees shall, for all Covered Products that do not contain an Average Level of 115 parts per billion or less, provide clear and reasonable warnings as set forth in Proposition 65 and related Regulations.
In the event that the Office of Environmental Health Hazard Assessment promulgates one or more regulations requiring or permitting warning text, permitting the absence of warning text, and/or permitting methods of transmission different than those set forth above, Defendant Releasees shall be entitled to use, at their discretion, such other warning text and/or method of transmission without being deemed in breach of this Consent Judgment.
2.3 Sell-Through Period
Notwithstanding anything else in this Settlement Agreement, Covered Products that were manufactured before the Effective Date shall be subject to a full release of all liability pursuant to this Consent Judgment, without regard to when such Covered Products were, or are in the future, distributed or sold to customers. The obligations of Defendant Releasees, do not apply to Covered Products manufactured before the Effective Date. Claims concerning those earlier manufactured products are released nonetheless.
2.4 Court Approval of Less Onerous Compliance Measures
If a California court approves a Proposition 65 consent judgment concerning acrylamide for one or more competitors of any Defendant Releasee that provides for materially less onerous compliance measures, the Court, upon application by Loacker, shall modify this Consent Judgment to replace the more onerous compliance measures set forth herein with those less onerous compliance measures.